| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |